Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
Background Percutaneous Hepatic Perfusion (PHP) is a liver directed regional therapy recently FDA approved for metastatic uveal melanoma to the liver involving percutaneous isolation of liver, saturation of the entire liver with high-dose chemotherapy and filtration extracorporeally though in line f...
Main Authors: | Sanjay Chandrasekhar, Matthew Perez, Zurain Niaz, Jahanzaib Ekram, Neelam Lal, Sarah Koly, Biwei Cao, Jonathan S. Zager, Mohammed Alomar |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/10732748241246898 |
Similar Items
-
Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
by: Kristy K Broman, et al.
Published: (2019-11-01) -
Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma
by: Lindsey Teal, et al.
Published: (2021-01-01) -
Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report
by: Damla Gunenc, et al.
Published: (2024-04-01) -
Multiregional genetic evolution of metastatic uveal melanoma
by: Daniel A. Rodriguez, et al.
Published: (2021-08-01) -
Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
by: Hakan Demirci, et al.
Published: (2013-01-01)